Your partner
in urogenital
preclinical research
Therapeutic Areas
Urology
A wide range of preclinical models of urological diseases.
Nephrology
An expertise on preclinical models for kidney pathologies
Oncology
From cells and organoids to human tumors-xenografts models.
Gynecology
A wide range of preclinical models of gynecological diseases.
Andrology
A wide range of preclinical models of males diseases.
Gastroenterology
An expertise on major gastrointestinal diseases.
Our
Platform
Our Platform
With an optimized platform and a pharmaceutical industry level of quality, Urosphere’s Platform offers more than 20 years of expertise and know-how in preclinical drug development through its in vivo and in vitro models.
News & Publications
News &
Publications
Bacterial nanoparticles as a potent and safe alternative to BCG for bladder cancer immunotherapy
Colson M. et al., 2025. Cancer Gene Therapy
Urosphere will be attending AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
Our team is eagerly awaiting to meet-up with you at Booth no.107 to share how our latest services and models can help bring your research programs a step further. From 22 to 26 October 2026 in Boston, USA For more information about Urosphere, please contact us
Urosphere will be attending the 41st Annual Meeting of ESHRE.
Urosphere is pleased to announce that our team will be attending ESHRE 2025 – the European Society of Human Reproduction and Embryology Annual Meeting. From 30 June to 2 July 2025 in Paris, France For more information about this event, please visit ESHRE website For more information about Urosphere, please contact us
Research &
Development
Research & Development
Our Partners
Our Company
As a member of the drug discovery value chain, Urosphere can support your project. Our experts and platforms are dedicated to meeting your needs. Our aim is to understand your challenges and objectives to develop customized solutions together.